"Do not forget the first heart, always young, try hard, innovation more than" 16-word proverb has always run through the spirit of the meeting of the New Vascular Congress. At VEITH 2023 Symposium, the Conference on New Vascular Diseases continued to adhere to the conference tenet of "down-to-earth innovation, seeking truth from facts, evidence-based, uniting win-win cooperation and standardizing exploration" and started again on November 16, focusing on the hotspots and difficulties in the treatment of critical vascular diseases, focusing on the key disciplinary issues such as pathogenesis, clinical diagnosis and treatment, quality control and clinical transformation, sharing new advances, new technologies and new concepts with global experts and scholars, fully displaying clinical experience and exchanging scientific research achievements in the field of vascular diseases, bringing multi-dimensional perspective and brand-new ideas to everyone, and struggling to promote the continuous development of vascular health cause and moving forward!

Vasco Knight, an innovation platform from China, will also hold the first meeting on the first day of VEITH Conference (November 14, 2023), which aims to promote Chinese experts and scholars to go abroad, introduce international innovative technology concepts into China and promote the exchange and development of the two sides. On this basis, CVC (Chinese Vascular Congress) from China will carry out in-depth cooperation with Veith.

The 50th Annual Symposium on Vascular and Endovascular Issues (VEITH 2023) meeting will be held 14-18 November 2023 at the Hilton Hotel, Central New York, USA. This conference will involve wonderful topics such as the best anti-plate regimen, the latest diagnosis and treatment of rare vascular diseases, progress in endovascular and open treatment of vascular trauma, topics related to complex popliteal artery diseases, application and development status of AR and AI technology.

The 8th China Vascular Congress (CVC 2023) was grand opened in Xi'an, the ancient capital of the millennium, from September 21 to September 24. Adhering to the concept of "Innovation, Transformation and Cooperation" and with the theme of "Smooth Blood Vessels and Long River of Life", this conference aims to promote the development of medical cause of vascular diseases in China, break disciplinary barriers and expand international vision. This conference has once again received extensive attention from industry experts and colleagues in the industry!

Recently, the innovative three branch stent system (CS stent) for the aorta, created by China and with full intellectual property rights, successfully completed its first application in Stanford B-type aortic dissection at Xiangya Second Hospital of Central South University. This innovative stent system provides a new solution for the full lumen treatment of Stanford B-type aortic dissection lesions involving the aortic arch, greatly optimizing the brain protection strategy for full lumen repair of the aortic arch in design, and is expected to help more patients avoid the huge trauma of thoracotomy surgery and significantly improve their quality of life.